The Kingdom of Saudi Arabia has positioned genomic healthcare prominently in the Vision 2030 initiative, with a key focus on personalized healthcare. Saudi Arabia is actively sequencing its population’s genomes and tailoring treatments based on...
VarSome.com VarSome Clinical VarSome Team
0
This new partnership will provide integrated end-to-end solutions from sample to report for whole genome nanopore sequencing in future clinical applications.
Press Releases Partnerships News
Lausanne, Switzerland, October 17,2023 – Saphetor SA today announces that it is partnering with world-leading healthcare intelligence and clinical research organization ICON to develop an innovative approach to support the planning and execution of...
Press Releases Partnerships News
Saphetor caught up with Constantia Aristidou from The Cyprus Institute of Neurology & Genetics (CING), that highlighted the breadth and scope of VarSome Clinical in their recently published paper; Exploring the Genetic Causality of Discordant...
Community VarSome.com VarSome Clinical VarSome in Action
When we ask people what they value most about VarSome, the most common response is “the classifiers”. In building our germline and somatic variant classifiers, we automated a very time-consuming and labor-intensive process. We apply the relevant...
VarSome.com VarSome Clinical VarSome.com Premium VarSome Team
Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...
We get a lot of great feedback on our classification tools. In particular, our germline classifier is a tool that healthcare professionals around the world constantly rely on to help them solve cases. This is because it implements recognized...
Technology VarSome API VarSome.com VarSome Clinical VarSome.com Premium ACMG
Saphetor is exhibiting at this year's European Society of Human Genetics conference in Glasgow, Scotland.
Aceragen, a biopharmaceutical company specializing in the development of treatments for rare genetic conditions, recently shared their novel approach to mapping Farber disease prevalence at ASHG 2022. Using VarSome Insights, the team were able to...
Saphetor Sa, A Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Maarten Kempen as Chief Commercial Officer, effective February 1st, 2023. Kempen will be responsible...
Our Head of Regulatory Affairs and Quality Assurance, Amélie Martinez, was featured in Inside Precision Medicine in an interview covering the upcoming impact and practical considerations labs are facing regarding IVDR.
